Subgroups
Outcomes (4)
- pain-headache-migraine-monthly-moderate-to-severe-headache-days-change-from-baseline-count-self-reported
- pain-headache-migraine-monthly-moderate-to-severe-headache-days-count-self-reported
- pain-headache-migraine-monthly-moderate-to-severe-headache-days-decrease-from-baseline-percent-self-reported
- pain-headache-migraine-monthly-moderate-to-severe-headache-hours-change-from-baseline-hours-self-reported
Protocols & scoring
medication-fremanezumab-subcut-monthly-migraine-protocol1 evidence row
medication-galcanezumab-high-dose-monthly-protocol2 evidence rows
medication-galcanezumab-monthly-loading-dose-protocol1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| pain-headache-migraine-monthly-moderate-to-severe-headache-days-change-from-baseline-count-self-reported | +45 | 85 | 115 |
medication-galcanezumab-monthly-with-loading-protocol1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| pain-headache-migraine-monthly-moderate-to-severe-headache-days-count-self-reported | +45 | 85 | 115 |
medication-placebo-injection-monthly-protocol1 evidence row
Path: pain › headache › migraine › monthly › moderate › to › severe